Subcutaneous infusion of levodopa-carbidopa beneficial for Parkinson's disease
Subcutaneous infusion of ND0612 (a levodopa-carbidopa solution) increases on time without troublesome dyskinesia among patients with Parkinson disease, according to a study published online March 15 in The Lancet Neurology.
Apr 13, 2024
0
4